Literature DB >> 21574893

Reliability of peak treadmill exercise tests in mild Alzheimer disease.

Heather S Anderson1, Patricia M Kluding, Byron J Gajewski, Joseph E Donnelly, Jeffrey M Burns.   

Abstract

INTRODUCTION: The purpose of this study was to determine the reliability of treadmill peak exercise testing in people with very mild-to-mild Alzheimer disease (AD).
METHODS: Sixteen subjects with very mild-to-mild AD performed graded peak treadmill exercise tests twice within a 14-day period. Heart rate, oxygen consumption, and respiratory exchange ratio (RER) were continuously monitored. Peak values were analyzed for absolute level of agreement.
RESULTS: Fourteen participants (87.5%) completed testing. Reliability was excellent with total peak oxygen consumption (VO2peak) (ml/kg/min) highly correlated across the two tests (r = 0.94, p < .001) with an intraclass correlation coefficient (ICC[3,1]) of 0.92 (95% confidence interval (CI) = 0.78, 0.97). The standard error of measurement (SEM) for VO2peak was 1.29 (95% CI = 0.88, 1.89).
CONCLUSIONS: These results indicate that peak exercise testing on a treadmill is reliable in the early stages of AD.

Entities:  

Mesh:

Year:  2011        PMID: 21574893      PMCID: PMC3143203          DOI: 10.3109/00207454.2011.574762

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  29 in total

1.  A comparative analysis of four protocols for maximal treadmill stress testing.

Authors:  M L Pollock; R L Bohannon; K H Cooper; J J Ayres; A Ward; S R White; A C Linnerud
Journal:  Am Heart J       Date:  1976-07       Impact factor: 4.749

2.  The reproducibility of VO2max, ventilatory, and lactate thresholds in elderly women.

Authors:  V L Foster; G J Hume; A L Dickinson; S J Chatfield; W C Byrnes
Journal:  Med Sci Sports Exerc       Date:  1986-08       Impact factor: 5.411

3.  A modified treadmill exercise protocol for computer-assisted analysis of the ST segment/heart rate slope: methods and reproducibility.

Authors:  P M Okin; O Ameisen; P Kligfield
Journal:  J Electrocardiol       Date:  1986-10       Impact factor: 1.438

Review 4.  Exercise performance and beta-blockade.

Authors:  P A Tesch
Journal:  Sports Med       Date:  1985 Nov-Dec       Impact factor: 11.136

5.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

Authors:  D A Evans; H H Funkenstein; M S Albert; P A Scherr; N R Cook; M J Chown; L E Hebert; C H Hennekens; J O Taylor
Journal:  JAMA       Date:  1989-11-10       Impact factor: 56.272

6.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

7.  Maximal exercise testing of mentally retarded adolescents and adults: reliability study.

Authors:  B Fernhall; A L Millar; G T Tymeson; L N Burkett
Journal:  Arch Phys Med Rehabil       Date:  1990-12       Impact factor: 3.966

8.  Submaximal exercise in persons with stroke: test-retest reliability and concurrent validity with maximal oxygen consumption.

Authors:  Janice J Eng; Andrew S Dawson; Kelly S Chu
Journal:  Arch Phys Med Rehabil       Date:  2004-01       Impact factor: 3.966

9.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

10.  Revision of the Physical Activity Readiness Questionnaire (PAR-Q).

Authors:  S Thomas; J Reading; R J Shephard
Journal:  Can J Sport Sci       Date:  1992-12
View more
  8 in total

1.  Determination of Aerobic Capacity via Cycle Ergometer Exercise Testing in Alzheimer's Disease.

Authors:  Ulf G Bronas; Dereck Salisbury; Kaitlin Kelly; Arthur Leon; Lisa Chow; Fang Yu
Journal:  Am J Alzheimers Dis Other Demen       Date:  2017-07-18       Impact factor: 2.035

2.  Validity of the step test for exercise prescription: no extension to a larger age range.

Authors:  Eric D Vidoni; Anna Mattlage; Jonathan Mahnken; Jeffrey M Burns; Joe McDonough; Sandra A Billinger
Journal:  J Aging Phys Act       Date:  2012-12-10       Impact factor: 1.961

3.  A community-based approach to trials of aerobic exercise in aging and Alzheimer's disease.

Authors:  Eric D Vidoni; Angela Van Sciver; David K Johnson; Jinghua He; Robyn Honea; Brian Haines; Jami Goodwin; M Pat Laubinger; Heather S Anderson; Patricia M Kluding; Joseph E Donnelly; Sandra A Billinger; Jeffrey M Burns
Journal:  Contemp Clin Trials       Date:  2012-08-07       Impact factor: 2.226

4.  Alzheimer disease alters the relationship of cardiorespiratory fitness with brain activity during the stroop task.

Authors:  Eric D Vidoni; Matthew R Gayed; Robyn A Honea; Cary R Savage; Derek Hobbs; Jeffrey M Burns
Journal:  Phys Ther       Date:  2013-04-04

5.  Cardiorespiratory fitness and white matter integrity in Alzheimer's disease.

Authors:  R D Perea; E D Vidoni; J K Morris; R S Graves; J M Burns; R A Honea
Journal:  Brain Imaging Behav       Date:  2016-09       Impact factor: 3.978

6.  Establishing Reference Cardiorespiratory Fitness Parameters in Alzheimer's Disease.

Authors:  Dereck Salisbury; Fang Yu
Journal:  Sports Med Int Open       Date:  2020-01-30

7.  "Body & Brain": effects of a multicomponent exercise intervention on physical and cognitive function of adults with dementia - study protocol for a quasi-experimental controlled trial.

Authors:  Joana Carvalho; Flávia Borges-Machado; Duarte Barros; Arnaldina Sampaio; Inês Marques-Aleixo; Lucimere Bohn; Andreia Pizarro; Laetitia Teixeira; José Magalhães; Óscar Ribeiro
Journal:  BMC Geriatr       Date:  2021-03-04       Impact factor: 3.921

8.  Change in Fitness and the Relation to Change in Cognition and Neuropsychiatric Symptoms After Aerobic Exercise in Patients with Mild Alzheimer's Disease.

Authors:  Nanna A Sobol; Christian Have Dall; Peter Høgh; Kristine Hoffmann; Kristian Steen Frederiksen; Asmus Vogel; Volkert Siersma; Gunhild Waldemar; Steen G Hasselbalch; Nina Beyer
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.